Ketogenic Diet-Induced Prurigo Pigmentosa (the Keto Rash): A Case Report and Literature Review
Any drug moving from prescription to OTC status must prove it is safe for unsupervised use by the general public, including people with multiple chronic conditions, pregnant individuals, and those on complex medication regimens
Because federal rules now limit when compounded copies of semaglutide and tirzepatide can be made, a careful provider will document a specific clinical reason a compounded option is right for you (FDA)
Compounded drugs themselves introduce another layer of exposure: pharmacies and fulfillment networks often hold parallel databases of patient information, creating a fragmented privacy ecosystem
Additionally, a healthier gut can lead to increased energy levels and improved mood
While semaglutide is no longer eligible for general compounding, other GLP-1 drugs, such as dulaglutide and liraglutide , remain on the FDAs Drug Shortage List